Cigna Group CI
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Cigna Group (CI) Core Market Data and Business Metrics
Latest Closing Price
$331.92Price-Earnings Ratio
31.46Total Outstanding Shares
271.11 Million SharesDividend
$1.51 Per Share QuarterlySIC Description
Hospital & Medical Service PlansPrimary Exchange
New York Stock ExchangeHeadquarters
900 Cottage Grove Road, Bloomfield, CT, 06002
Historical Stock Splits
If you bought 1 share of CI before June 5, 2007, you'd have 3 shares today.
| Execution Date | Split Amount |
|---|---|
| June 5, 2007 | 3-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,806,952 Shares | 2.06 | 3/14/2025 | 3,714,300 Shares |
| 2,023,295 Shares | 1.91 | 2/28/2025 | 3,859,901 Shares |
| 1,696,952 Shares | 2.16 | 2/14/2025 | 3,669,290 Shares |
| 2,214,991 Shares | 1.86 | 1/31/2025 | 4,115,125 Shares |
| 1,453,245 Shares | 2.86 | 1/15/2025 | 4,160,155 Shares |
| 2,535,389 Shares | 1.91 | 12/31/2024 | 4,835,532 Shares |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-1.38 Billion |
| Net Cash Flow From Investing Activities, Continuing | $-2.35 Billion |
| Net Cash Flow From Financing Activities, Continuing | $-5.65 Billion |
| Net Cash Flow From Operating Activities | $6.62 Billion |
| Net Cash Flow, Continuing | $-1.38 Billion |
| Net Cash Flow From Operating Activities, Continuing | $6.62 Billion |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Operating Income/Loss | $9.30 Billion |
| Selling, General, and Administrative Expenses | $15.04 Billion |
| Other Operating Expenses | $39.49 Billion |
| Preferred Stock Dividends And Other Adjustments | $0 |
| Costs And Expenses | $223.28 Billion |
| Net Income/Loss | $3.35 Billion |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $3.31 Billion |
| Comprehensive Income/Loss Attributable To Parent | $3.00 Billion |
| Other Comprehensive Income/Loss | $-44 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $310 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Current Assets | $49.22 Billion |
| Noncurrent Liabilities | $58.28 Billion |
| Current Liabilities | $57.06 Billion |
| Accounts Receivable | $27.85 Billion |
| Liabilities | $115.34 Billion |
| Temporary Equity | $0 |
Historical Dividends
Current dividend: $1.51 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 30, 2025 | Mar 20, 2025 | Mar 5, 2025 | $1.51 | Quarterly |
| Oct 23, 2024 | Dec 19, 2024 | Dec 4, 2024 | $1.4 | Quarterly |
| Jul 24, 2024 | Sep 19, 2024 | Sep 4, 2024 | $1.4 | Quarterly |
| Apr 24, 2024 | Jun 20, 2024 | Jun 4, 2024 | $1.4 | Quarterly |
| Feb 2, 2024 | Mar 21, 2024 | Mar 6, 2024 | $1.4 | Quarterly |
| Oct 25, 2023 | Dec 21, 2023 | Dec 6, 2023 | $1.23 | Quarterly |